Longer progression-free survival with targeted therapy for patients with metastatic breast cancer. Nierengarten MB. Cancer 2025;131:e35790.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Longer progression-free survival with targeted therapy for patients with metastatic breast cancer. Cancer 2025;131:e35790.
PMID: 40178172